AeroLeads people directory · profile
Qiang (Peter) Ding Email & Phone Number
Co-Founder and CEO
at
Allorion Therapeutics
LinkedIn matched
✓ Verified May 2026
3 data sources
Profile completeness 100%
Current company
Role
Co-Founder and CEO
Location
Guangzhou, Guangdong, China
Company size
Who is Qiang (Peter) Ding? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Qiang (Peter) Ding is listed as Co-Founder and CEO at Allorion Therapeutics, a company with 34 employees, based in Guangzhou, Guangdong, China. AeroLeads shows a matched LinkedIn profile for Qiang (Peter) Ding.
Qiang (Peter) Ding previously worked as Co-Founder/CEO at Allorion Therapeutics and Co-Founder/R&D Head at Curegenix. Qiang (Peter) Ding studied at Rutgers University.
Company email context
Email format at Allorion Therapeutics
This section adds company-level context without repeating Qiang (Peter) Ding's masked contact details.
Allorion Therapeutics
Review company-level records connected to Qiang (Peter) Ding before choosing the right outreach path.
Profile bio
About Qiang (Peter) Ding
Peter Ding is a highly accomplished professional with over 20 years of expertise in small molecule drug discovery. He possesses a strong background in innovative drug preclinical research and development, as well as an in-depth understanding of companion diagnosis strategy, IND filing processes in the US and China, and early stage dose escalation and POC clinical trials.Peter is also a co-founder of two reputable biotech startup companies, Curegenix and Allorion Therapeutics. His entrepreneurial spirit and strategic leadership have played a pivotal role in driving these ventures towards success.
Listed skills include Teaching.
Current workplace
Qiang (Peter) Ding's current company
Company context helps verify the profile and gives searchers a useful next step.
Allorion Therapeutics
4 roles
Qiang (Peter) Ding work experience
A career timeline built from the work history available for this profile.
Co-Founder/Ceo
CurrentAllorionTx is a biotech company focus on small molecule drug discovery targeting autoimmune disease and cancer by using innovative technology and discovery platform.
Jun 2020 - Present
Co-Founder/R&D Head
Curegenix
Discovery and development of first-in-class small molecule WNT inhibitor CGX1321, and now in Phase Ib/II clinical trials for advanced GI tumors both in single drug and combo with Pembrolizumab (Keynote 596).
Jun 2011 - Feb 2020
Research Investigator Ii
Lead several kinase inhibitor drug discovery projects and regenerative medicine project as a medicinal chemist.
Jun 2000 - May 2011
2 education records
Qiang (Peter) Ding education
Education record
Education record
FAQ
Frequently asked questions about Qiang (Peter) Ding
Quick answers generated from the profile data available on this page.
What company does Qiang (Peter) Ding work for?
Qiang (Peter) Ding works for Allorion Therapeutics.
What is Qiang (Peter) Ding's role at Allorion Therapeutics?
Qiang (Peter) Ding is listed as Co-Founder and CEO at Allorion Therapeutics.
Where is Qiang (Peter) Ding based?
Qiang (Peter) Ding is based in Guangzhou, Guangdong, China while working with Allorion Therapeutics.
What companies has Qiang (Peter) Ding worked for?
Qiang (Peter) Ding has worked for Allorion Therapeutics, Curegenix, and Gnf.
How can I contact Qiang (Peter) Ding?
You can use AeroLeads to view verified contact signals for Qiang (Peter) Ding at Allorion Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Qiang (Peter) Ding attend?
Qiang (Peter) Ding studied at Rutgers University.
What skills is Qiang (Peter) Ding known for?
Qiang (Peter) Ding is listed with skills including Teaching.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial